IX Biopharma News

General Announcement-Press Release - Business and Drug Development Updates - Wafermine and iXB 401

Sep 16 17:37

General Announcement-Press Release - New Study Demonstrates that SL-NAD+ Delivers NAD+ into Cells

Sep 2 07:12

General Announcement-Press Release - New Study Highlights CBD Wafer's Potential in Kidney Failure Patients

Aug 12 18:50

REPL-General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 22 17:39

General Announcement-Issue and Listing of the Rights Shares and the Warrants

Jul 19 18:16

IX Biopharma: General Announcement-Notice From Undertaking Shareholder Anson Properties Pte. Ltd.

Jul 15 17:44

IX Biopharma: General Announcement-Press Release - Breakthrough Sublingual Wafers Raise NAD+ Levels, Enhance Well-Being in Human Trial

Jul 9 18:57

IX Biopharma: General Announcement-Proposed Renounceable Non-Underwritten Rights Cum Warrants Issue-Despatch of Notification and Forms

Jul 1 17:55

IX Biopharma: General Announcement-Notice of Adjustment to Conversion Price of 9% Convertible Bonds Principal Amount S$2 Million

Jun 18 17:56

IX Biopharma: General Announcement-Update For Shareholders

Mar 20 18:51

IX Biopharma: General Announcement-Press Release - iX Biopharma Announces Development of Semaglutide Sublingual Wafer, iXB 401

Mar 11 17:30

IX Biopharma: General Announcement-Press Release - iX Biopharma Unveils Novel NAD Wafers

Mar 4 17:25

IX Biopharma: General Announcement-Termination Of Wafermine Licensing Agreement

Mar 1 17:20

IX Biopharma: General Announcement-Notice Of Termination Of Wafermine Licensing Agreement

Nov 17, 2023 22:35

IX Biopharma: General Announcement-Change of Address of Share Registrar and Place Where Register of Members and Index Is Kept

Nov 14, 2023 17:32

IX Biopharma: General Announcement-Minutes of Annual General Meeting Held on 13 October 2023

Nov 10, 2023 17:37

IX Biopharma: REPL-Annual General Meeting-Voluntary

Oct 13, 2023 19:06

IX Biopharma: General Announcement-Responses to Questions from the Securities Investors Association (Singapore)

Oct 12, 2023 07:11

IX Biopharma: General Announcement-Questions & Answers Provided by iX Biopharma Ltd for Annual General Meeting on 13 October 2023

Oct 6, 2023 17:37

IX Biopharma: General Announcement-Corrigenda - Corporate Governance Reports 2022 and 2023

Oct 4, 2023 19:44